Diasome Pharmaceuticals, Inc. — Form D/A

Diasome Pharmaceuticals, Inc. of CLEVELAND, OH, a company, filed a Form D amendment with the SEC on 2009-04-13. The offering totals $13.4M, of which $12.9M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Richard CarusoDirectorVillanova, PA
Brenda GavinDirectorPhiladelphia, PA
Devang KantesariaDirectorMiami, FL
Len RosenbergDirectorConshohocken, PA
Len RosenbergExecutive OfficerConshohocken, PA
Marc PennDirectorCleveland, OH
Peter Blair TollmanDirectorCleveland, OH
Robert GehoDirectorCleveland, OH
Robert GehoExecutive OfficerCleveland, OH
Robert GehoPromoterCleveland, OH
Frank Blair McCaneyDirectorCleveland, OH
W. Blair GehoDirectorCleveland, OH
W. Blair GehoExecutive OfficerCleveland, OH
Thomas Blair McDonaldDirectorCleveland, OH
Cosme Blair OrdonezDirectorCleveland, OH
Thomas McDonaldDirectorMiami, FL
Marc Blair PennDirectorCleveland, OH
Frank McCaneyDirectorPhiladelphia, PA
W. Blair GehoDirectorCleveland, OH
Michele Blair OllierDirectorCleveland, OH
Helga Blair KautskyExecutive OfficerCleveland, OH
Guiseppe Blair ZoccoDirectorCleveland, OH
Richard Blair CarusoDirectorCleveland, OH

Other filings by this issuer (7)

FiledFormOfferingSold
2024-08-15D$15.6M$3.1M
2023-06-30D$15.0M$9.0M
2022-09-08D$19.1M$16.7M
2020-12-23D$5.0M$1.5M
2020-04-01D$2.9M$2.9M
2018-10-26D$18.6M$12.1M
2017-01-17D$8.0M$4.3M

More